Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced <i>BRAF</i>-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134
National Cancer Institute (NCI)
Michael B Atkins; Sandra J Lee; Bartosz Chmielowski; Ahmad A Tarhini; Gary I Cohen; Thach-Giao Truong; Helen H Moon; Diwakar Davar; Mark O'Rourke; Joseph J Stephenson; Brendan D Curti; Walter J Urba; Joanna M Brell; Pauline Funchain; Kari L Kendra; Alexandra P Ikeguchi; Anthony Jaslowski; Charles L Bane; Mark A Taylor; Madhuri Bajaj; Robert M Conry; Robert J Ellis; Theodore F Logan; Noel Laudi; Jeffrey A Sosman; David G Crockett; Andrew L Pecora; Ian J Okazaki; Sowjanya Reganti; Sunandana Chandra; Samantha Guild; Helen X Chen; Howard Z Streicher; Jedd D Wolchok; Antoni Ribas; John M Kirkwood